Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

24
Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002

Transcript of Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Page 1: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Introduction To Haematological Malignancies

By Tiffany Shaw

MBChB II

July 2002

Page 2: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Common Malignancies

Acute Chronic

Lymphoid Acute lymphoblastic leukemia

Chronic lymphocytic leukemia

Lymphoma

Myeloma

Myeloid Acute myeloid leukemia Chronic myeloid leukemia

Page 3: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias -- Definition

A malignant disorder in which haemopoietic blast cells proliferate and constitute > 30% of the bone marrow.

Lymphoblasts Lymphoblastic leukemia

Myeloblasts Myeloid leukemia

Page 4: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias -- PC

1. Bone marrow infiltrated by blasts cells2. Bone marrow failure3. Pan-cytopenia4. Anaemia fatigue, SOB on exersion5. Thrombocytopenia bleeding / DIC6. Neutropenia infections7. Constitutional symptoms (malaise,

anorexia, night sweat, fever)8. Lymphadenopathy, hepatospenomegaly

Page 5: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias -- Ix

1. Low Hb

2. Low platelets

3. High WCC (increased blast cells)

4. Low neutrophils

5. Elevated serum uric acid

6. Bone marrow biopsy: infiltration by blast cells

Page 6: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias – Risk Factors

Familial

Down’s syndrome

Viral infection (EBV Burkitt’s)

Radiation

Chemotherapy

Page 7: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias – AML VS ALL

AMLMyeloblastic

Any age

1/3 transformation from other myeloproliferative disorders

Increased DIC

ALLLymphoblastic

Commonly children

Primary event

More lymphadenopathy and hepatosplenomegaly

Page 8: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias -- Classification

French-American-British Classification

Morphology

Cytochemistry

Immunophenotype

Cytogenetics

DNA analysis

Page 9: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Examples

AML

Promyelocytic

Myelomonocytic

Monocytic

Erythroid

Megakeryoblastic

Undifferentiated

…. ect.

ALL

Small cells

Large cells

Vacuolated basophillic blast cells

Page 10: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias -- Mx

Supportive Rx

Anaemia: blood transfusion prn

Bleeding: platelets prn

Infection: antibiotics prn

Social support + issues

Page 11: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias -- Mx

Chemotherapy:

Remission-induction phase

Consolidation phase

Maintenance phase (for ALL)

prednisone, daunorubicin, vincristine, thioguanine, cyclophosphamide…

Page 12: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias -- Mx

Bone Marrow Transplantation:

High-dose chemo Rx

Removal of stem cells from donor

Transplantation into recipient

Page 13: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Acute Leukemias -- Prognosis

AML

~ 30-40% cured

Varies widely with age, co-morbidity..etc.

ALL

In children, ~ 70% cured

In adults, ~ 30-40%

Page 14: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Chronic Myeloid Leukemia

Increase in neutrophils and their precursors

Really a myeloproliferative disorder

> 95% patients have chromosomal mutation --- Philadelphia chromosome

Page 15: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

CML -- PC

Constitutional symptoms (anorexia, weight loss, fatigue, night sweat)

Splenomegaly (hypochondrial pain)

Asymptomatic – incidental finding

Page 16: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

CML -- Ix

Increased WCC (neutrophils and precursors)Later bone marrow failure (anaemia + thrombocytopenia)Raised serum B12Raised serum uric acidBone marrow biopsy hypercellular with high myeloid:erythroid ratio

Page 17: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

CML – Course/Progression

Chronic PhaseRaised WCCConstitutional symptoms / Asymptomatic

Accelerated PhaseAnaemia + thrombocytopeniaSplenomegalyBone marrow fibrosis

Acute PhaseTransformation to acute leukemia (80% AML, 20% ALL)

Page 18: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

CML -- Mx

Chronic PhaseHydroxyurea

Interferons

Chemo Rx

Bone marrow transplantation

Acute PhaseSame as acute leukemia

Page 19: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

Chronic Lymphcytic Leukemia

Increased lymphocytes (B cells) in the blood, bone marrow, lymph nodes, and spleen.

Lymphoproliferative disorder

Page 20: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

CLL -- PC

Asymptomatic

Lymphadenopathy

Constitutional symptoms (night sweat, weight loss, anorexia)

Symptoms of bone marrow failure

Splenomagaly

Page 21: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

CLL -- Ix

Lymphocytosis (B cells)

Low serum Ig

Raised serum uric acid

Bone marrow biopsy lymphocytic infiltration

Page 22: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

CLL -- Ix

Depends on stage:

Stage A B C

< 3 lymph node groups involvement

Bloods normal

> 3 lymph node groups involvement

Bloods normal

Bloods abnormal (anaemia + thrombocytopenia)

Page 23: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

CLL -- Mx

1. Observation (stage A)

2. Chlorambucil PO (lower lymphocyte count and lymphadenopathy)

3. Corticosteroid

4. Fludarabine IV

5. Other chemo Rx

6. Supportive care

Page 24: Introduction To Haematological Malignancies By Tiffany Shaw MBChB II July 2002.

CLL -- Prognosis

Variable

May remain stationary or progress

Some stay asymptomatic for > 10 years

Cause of death = bone marrow failure, infiltration of other organs